Physician Assistant Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Jenna Brothers

Physician Assistant, Medical Durham, NC Physician Assistant

NPI 1407278146 CMS profile 10418737

200 Trent Dr, Durham, NC 27710

Open in the dashboard

General payments

$10,397

16 records reported · program years 2023–2025

Research payments

$410

Paid to them · 1 record reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jenna Brothers of Durham, NC is reported in the CMS Open Payments database as having received $10,397 across 16 general payments and $410 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,135 13
2024 General $137 2
2023 General $125 1
2023 Research $410 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jenna Brothers
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Jenna Brothers were reported at $10,135. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Jenna Brothers Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $0 $156 $41–$563 $132
2022 $0 $185 $55–$649 $149
2023 $125 $199 $58–$717 $160
2024 $137 $206 $62–$740 $164
2025 $10,135 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Sequel Med Tech, LLC $10,152 14 payments
  2. Horizon Therapeutics plc $125 1 payment
  3. Medtronic, Inc. $120 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Consulting Fee $7,496 7 payments
  2. Travel and Lodging $2,177 3 payments
  3. Food and Beverage $724 6 payments
Products named General payments · program years 2023–2025
  1. TWIIST $10,135 13 payments
  2. TEPEZZA $125 1 payment
  3. MINIMED 780G $120 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2023–2025
  1. Dexcom, Inc. $410 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 60 drugs

Part D claims

2,466

Median for Physician Assistant: 241

Drug cost

$1,446,567

Median for Physician Assistant: $4,110

Branded share of claims

61.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mounjaro Tirzepatide Brand 176 $265,417
Ozempic Semaglutide Brand 153 $236,154
Somavert Pegvisomant Brand 12 $196,888
Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 Brand 82 $153,715
Jardiance Empagliflozin Brand 87 $106,178
Tresiba Flextouch U-200 Insulin Degludec Brand 51 $81,800
Humalog Kwikpen U-200 Insulin Lispro Brand 15 $53,516
Tresiba Flextouch U-100 Insulin Degludec Brand 96 $52,274
Trulicity Dulaglutide Brand 24 $30,243
Fiasp Flextouch Insulin Aspart (Niacinamide) Brand 24 $27,319

The 10 drugs with the highest cost, of 60 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$27,878

Medicare's payments for the services billed

Medicare patients

146

Average age 71

Services billed

785

95 women, 51 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Diabetes 75%
High blood pressure 75%
Arthritis 42%
Chronic kidney disease 40%
Ischemic heart disease 35%
Depression 35%
Osteoporosis 24%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

17 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record